City of Hope teams with Caltech on new cancer and HIV/AIDS therapies
October 17, 2011 | by City of Hope Staff
Scientists from City of Hope and the California Institute of Technology (Caltech) have joined forces on biomedical and bioengineering research projects that may ultimately boost treatment for cancer, diabetes and other diseases.
Through the Caltech/City of Hope Biomedical Research Initiative, four scientific teams have split grants totaling $400,000. The new grants support research into gene therapy for HIV/AIDS and cancer, genetic profiling of cancer stem cells and testing drug targets for leukemia.The research initiative was established in 2008 through a $3 million seed gift and supports research projects between the two institutions.
“When we effectively apply the strengths of both City of Hope and Caltech to scientific research, we can more easily leverage groundbreaking discovery into the development of improved therapies for people facing serious illness such as cancer, HIV or diabetes,” said Michael A. Friedman, M.D., president and chief executive officer of City of Hope and the Irell & Manella Cancer Center Director’s Distinguished Chair.